Main Content start here
Main Layout
Report Description

Report Description

The United Kingdom veterinary medicine market is anticipated to witness a robust CAGR in the forecast period, 2023-2027. The surge in awareness about the adverse effects of zoonotic and foodborne diseases and efforts by the market players to optimize the supply chain and manufacturing of medicines are the primary factors driving the demand for the United Kingdom veterinary medicine market over the forecast period. Also, a rise in the launch of new products and medicines and increasing consumer willingness to spend on animal healthcare are the other prominent factors that are expected to accelerate the growth of the United Kingdom veterinary medicine market.

Increased Consumer Spending on Animal Healthcare Drives the Market Growth

Consumer spending on veterinary and other pet services in the United Kingdom in 2020 amounted million GBP 3993. The trend of pet humanization and the rise in the spending by pet owners to maintain animal health are playing a major role in influencing the market demand. People are becoming more dependent on pets for emotional support and are spending significant amounts on animal health and well-being. The most popular pets in the United Kingdom are cats, dogs, rabbits, indoor birds, guinea pigs, hamsters, tortoises, turtles, lizards, domestic fowls, and snakes. People prefer to keep pets as they improve their mental health and bring positivity to homes. People spend more than £3 billion on pet food every year. About more than half of pet owners live in cities, and most of the pet owners are under the age of 40. The huge popularity of pets and improved living standards of pet owners are expected to accelerate the United Kingdom veterinary medicine market growth in the forecast period.

Growing Prevalence of Diseases in Animals Fuels the Market Demand

Zoonotic and food-borne diseases are common in animals. The British government has spent about GBP 70 million a year on disease control and prevention. Bovine tuberculosis (bTB), which is caused by Mycobacterium bovis, is one of the most serious health problems faced by cattle in the country. Market players are launching products specifically for the health problems faced by animals, such as the introduction of BRAVECTO Plus medicine, which is used to treat external and internal parasite infections of cats. In 2019, veterinary activities contributed 2.7 billion British pounds to the GVA of the UK Non-Financial Business Economy, and this number is rapidly growing in the coming years. An increase in awareness about the negative effects of different diseases in animals and the availability of advanced treatment facilities are expected to drive the demand for the United Kingdom veterinary medicine market in the next five years.

Supportive Government Policies Favors the Market Growth

Leading authorities are keen on ensuring the well-being and health of animals and are introducing several initiatives and making hefty investments in the development of the animal healthcare industry. The Animal Welfare Act 2006 states that the animal owners need to take care of their pets, failing which they could be banned from owning animals or face an unlimited fine or sent to prison for up to six months. Also, the Welfare of Farmed Animals (England) (Amendment) Regulations 2010 protects the farm animals from any kind of cruelty and negligence by the pet owners. Therefore, the focus of the government on well-fare is expected to create lucrative growth opportunities for the United Kingdom veterinary medicine market in the forecast period.


Click here to download the sample

Market Segmentation

United Kingdom veterinary medicine market is segmented into animal type, product type, end user, source, regional distribution, and competitive landscape. Based on animal type, the market is bifurcated into production v/s companion. The production segment is further divided into poultry, swine, cattle, others while the companion segment is divided into dogs, cats, horses, others. Based on product type, the market is divided into vaccine, pharmaceuticals, and medicated feed additives. Based on end user, the market is divided into veterinary hospitals & clinics, reference laboratories, and others. Based on source, the market is bifurcated into domestic and import. United Kingdom veterinary medicine market is studied in major regions namely London, Southeast, East Anglia, Scotland, Southwest, East Midlands, Yorkshire & Humberside, and rest of United Kingdom.

Market Players

Dechra Pharmaceuticals PLC, Norbrook Laboratories Ltd, Elanco Animal Health UK Limited, Bayer Plc., Boehringer Ingelheim Animal Health UK Limited, Ceva Animal Health Limited, Covetrus Animal Health Holdings Limited, KRKA UK Ltd, TVM UK, Vetoquinol UK Limited, are the major market players operating in United Kingdom veterinary medicine market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Animal Type

·         Product Type

·         End User

·         Source

Regional scope

London, Southeast, East Anglia, Scotland, Southwest, East Midlands, Yorkshire & Humberside, Rest of United Kingdom

Key companies profiled

Dechra Pharmaceuticals PLC, Norbrook Laboratories Ltd, Elanco Animal Health UK Limited, Bayer Plc., Boehringer Ingelheim Animal Health UK Limited, Ceva Animal Health Limited, Covetrus Animal Health Holdings Limited, KRKA UK Ltd, TVM UK, Vetoquinol UK Limited

Customization scope

10% free report customization with purchase. Addition or alteration to regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, United Kingdom veterinary medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         United Kingdom Veterinary Medicine Market, By Animal Type:

    • Production
      • Poultry
      • Swine
      • Cattle
      • Others
    • Companion
      • Dogs
      • Cats
      • Horses
      • Others
  • United Kingdom Veterinary Medicine Market, By Product Type:
    • Vaccine
    • Pharmaceuticals
    • Medicated Feed Additives
  • United Kingdom Veterinary Medicine Market, By End User:
    • Veterinary Hospitals & Clinics
    • Reference Laboratories
    • Others
  • United Kingdom Veterinary Medicine Market, By Source:
    • Domestic
    • Import
  • United Kingdom Veterinary Medicine Market, By Region:

o   London

o   Southeast

o   East Anglia

o   Scotland

o   Southwest

o   East Midlands

o   Yorkshire & Humberside

    • Rest of United Kingdom

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United Kingdom veterinary medicine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
United Kingdom veterinary medicine market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]
Table of content

Table of content

1.     Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United Kingdom Veterinary Medicine Market

4.    Executive Summary

5.    Voice of Customers

6.    United Kingdom Veterinary Medicine Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Animal Type (Production v/s Companion)

6.2.1.1.         By Production (Poultry, Swine, Cattle, Others)

6.2.1.2.         By Companion (Dogs, Cats, Horses, Others)

6.2.2.     By Product Type (Vaccine, Pharmaceuticals, Medicated Feed Additives)

6.2.3.     By End User (Veterinary Hospitals & Clinics, Reference Laboratories, Others)

6.2.4.     By Source (Domestic v/s Import)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    United Kingdom Veterinary Vaccine Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type (Inactive Vaccines, Attenuated Vaccines, Recombinant Vaccines, Others)

7.2.2.     By End User

7.2.3.     By Source

8.    United Kingdom Veterinary Pharmaceuticals Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type (Parasiticides, Analgesics, Anti-Inflammatory, Anti-infectives, Others)

8.2.2.     By End User

8.2.3.     By Source

9.    United Kingdom Veterinary Medicated Feed Additives Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type (Aminoacids, Antibiotics, Others)

9.2.2.     By End User

9.2.3.     By Source

10.  Market Dynamics

10.1.  Drivers

10.2.  Challenges

11.  Market Trends & Developments

12.  Policy & Regulatory Landscape

13.  Import-Export Analysis

14.  United Kingdom Economic Profile

15.  Competitive Landscape

15.1.              Dechra Pharmaceuticals PLC

15.2.              Norbrook Laboratories Ltd

15.3.              Elanco Animal Health UK Limited

15.4.              Bayer Plc.

15.5.              Boehringer Ingelheim Animal Health UK Limited

15.6.              Ceva Animal Health Limited

15.7.              Covetrus Animal Health Holdings Limited

15.8.              KRKA UK Ltd

15.9.              TVM UK

15.10.            Vetoquinol UK Limited

16. Strategic Recommendations

Figures and Tables

Frequently asked questions

Frequently asked questions

The surge in awareness about the adverse effects of zoonotic and foodborne diseases and the launch of new drugs are driving the demand for the United Kingdom veterinary medicine market.

Dechra Pharmaceuticals PLC, Norbrook Laboratories Ltd, Elanco Animal Health UK Limited, Bayer Plc., Boehringer Ingelheim Animal Health UK Limited, Ceva Animal Health Limited, Covetrus Animal Health Holdings Limited, KRKA UK Ltd, TVM UK, Vetoquinol UK Limited are the key players operating in the United Kingdom veterinary medicine market.

The high cost of veterinary medicines may hinder the market growth in the forecast period.

Based on product type, the market is divided into vaccine, pharmaceuticals, and medicated feed additives. Pharmaceuticals are expected to hold the largest market share in the forecast period.

Related Reports